肺癌病灶中局限性的FDG丢失
本研究纳入11例肺癌分期患者,行动态PET/CT,逐体素Patlak分析并逐步延迟起始帧,发现延迟最明显的参数图中负斜率体素占肿瘤体积0.5–4.5%(中位2%),主要位于病灶边缘,与炎症浸润部位相符。
要点
- 逐体素 compartmental 分析可识别FDG放射性洗脱的肿瘤区域。
- 最延迟参数图中负斜率体素占肿瘤体积0.5–4.5%(中位2%)。
- 该洗脱模式主要位于病灶边缘,与炎症浸润位置相符。
核心结论
- 逐体素参数图可识别具有放射性洗脱特征的可测量体积,其空间定位与肿瘤间质中炎症浸润的已知好发部位相符。
研究设计与样本
- 研究纳入11例因分期目的接受PET/CT显像的肺癌患者。
- 肿瘤定义为围绕病灶绘制感兴趣体积,并纳入其中SUV>最大值40%的所有体素。
- 在心脏为中心动态显像20分钟后重复8次全身扫描。
- 对每个体素计算Patlak回归线,逐步生成6张参数图,分别采用全部8帧、最后7帧直至最后3帧。
主要发现
- 逐步延迟compartmental分析的起始点,负斜率体素的患病率逐渐增加。
- 在最延迟的参数图中,负斜率体素占肿瘤体积0.5–4.5%(中位2%)。
- 该效应与肿瘤大小无关,且主要位于病灶边缘。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Analysis of [18F]-Fluorodeoxyglucose (FDG) kinetics in cancer has been most often limited to the evaluation of the average uptake over relatively large volumes. Nevertheless, tumor lesions also contain inflammatory infiltrates whose cells are characterized by a significant radioactivity washout due to the hydrolysis of FDG-6P catalyzed by glucose-6P phosphatase. The present study aimed to verify whether voxel-wise compartmental analysis of dynamic imaging can identify tumor regions characterized by tracer washout. The study included 11 patients with lung cancer submitted to PET/CT imaging for staging purposes. Tumour was defined by drawing a volume of interest loosely surrounding the lesion and considering all inside voxels with a standardized uptake value (SUV) > 40% of the maximum. Eight whole-body scans were repeated after 20 min of dynamic imaging centered on the heart. Six parametric maps were generated progressively by computing a Patlak regression line for each voxel. Each analysis considered a different set of frames: starting with all eight frames, then the last seven frames, and so on, down to the last three frames. RESULTS: Delaying the starting point of the compartmental analysis revealed a progressive increase in the prevalence of voxels with a negative slope. In the most delayed parametric map, these voxels represented 0.5-4.5% (median 2%) of the tumor volume. This effect was independent of tumor size and was predominantly located at the lesion borders. CONCLUSIONS: The voxel-wise parametric maps provided by compartmental analysis identify a measurable volume characterized by radioactivity washout. The spatial localization of this pattern is compatible with the recognized preferential site of inflammatory infiltrates populating the tumor stroma and might improve the power of FDG imaging in monitoring the effectiveness of treatments aimed at empowering the host immune response against cancer. TRIAL REGISTRATION: ClinicalTrials. The study was approved by the local ethical committee and it represented a single Institution ancillary trial within the expanded-access program for Nivolumab. NCT02475382. Registered 2015-06-16. URL: https://clinicaltrials.gov/study/NCT02475382?id=NCT02475382.&rank=1.
引用
- Parodi D, Dighero E, Biddau G, et al. Localized FDG loss in lung cancer lesions. EJNMMI Res. 2024. PMID: 39485534. doi:10.1186/s13550-024-01161-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。